Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen

Anti-PM/Scl antibodies represent a specific serological marker for a subset of patients with scleroderma (Scl) and polymyositis (PM), and especially with the PM/Scl overlap syndrome (PM/Scl). Anti-PM/Scl reactivity is found in 24% of PM/Scl patients and is found in 3–10% of Scl and PM patients. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahler, Michael, Raijmakers, Reinout, Dähnrich, Cornelia, Blüthner, Martin, Fritzler, Marvin J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174964/
https://www.ncbi.nlm.nih.gov/pubmed/15899056
http://dx.doi.org/10.1186/ar1729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174964/
https://www.ncbi.nlm.nih.gov/pubmed/15899056
http://dx.doi.org/10.1186/ar1729

Ejemplares similares